UNSPSC 51284701: Xibornol

This classification denotes a bornane and alcohol with the molecular formula C18H26O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier RQ12GMY0FZ, chemically known as 3,4-xylenol, 6-isobornyl- (8ci) but generally known as xibornol, which bears US NIH Compound Identifier 72144. European Medicines Agency schedules Xibornol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00111MIG. World Health Organization schedules xibornol in its Anatomical Therapeutic Chemical (ATC) Classification.

XIBORNOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule xibornol under HS 29071990 and SITC 51243. As of Q4 2014, XIBORNOL remains the US FDA Preferred Term for this commodity. SMILES: OC1C(C2C3(C(C(C2)CC3)(C)C)C)CC(C(C1)C)C.

UNSPSC 51284701 Xibornol, a Commodity code, shows minimal recent state and local procurement activity aligned with its nominal scope. The two opportunities in the recent record do not involve xibornol; instead, they cover pharmaceutical warehouse supply (doxycycline and ciprofloxacin) and naloxone with drug deactivation systems. State and local governments procuring under this code are sourcing specialty pharmaceuticals through existing contracts and piggyback arrangements, often with multi-year terms and quarterly or as-needed delivery schedules. Issuing bodies include state health departments and county health authorities; the Illinois Department of Public Health and Seminole County, Florida appear in the recent record. Neither opportunity specifies xibornol explicitly, suggesting the code may be misapplied in tagging or that procurement demand under this specific pharmaceutical identifier is not currently active at the state and local level.

Illinois and Florida represent the jurisdictions in the available recent opportunities. The Illinois Department of Public Health awarded a $2,999,999.11 piggyback pharmaceutical warehouse contract to Chartwell Rx LLC on August 28, 2026, covering doxycycline and ciprofloxacin tablets under a 12-month initial term with two optional renewal years; this was a completed award, not an open solicitation. Seminole County, Florida issued an IFB on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building, due July 26, 2023 (note: the due date predates the posted date, indicating a data quality issue in the source record). Absent additional recent opportunities directly naming xibornol, the code does not presently signal active procurement demand at the state and local level.